Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and Disease    2011, Vol. 2 Issue (6) : 466-473     DOI:
|
Frailty, Inflammation, and Immunity
Huifen Li, Bhavish Manwani, Sean X. Leng
Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
Download: PDF(390 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Frailty is an important geriatric syndrome that is characterized by multisystem dysregulation, leading to decreased physiological reserve and increased vulnerability for adverse health outcomes. A large number of studies have shown a heightened inflammatory state marked by elevated levels of inflammatory molecules, such as IL-6 and C-reactive protein (CRP), and increased counts of white blood cell (WBC) and WBC subpopulations in frail older adults. It has been postulated that this heightened inflammatory state, or chronic inflammation, may play an important role in the pathogenesis of frailty, directly or through its detrimental influence to other physiologic systems. Inflammatory and immune activation mediated by monocytes and macrophages demonstrated by upregulated expression of specific stress responsive inflammatory pathway genes and elevated neopterin levels may contribute, at least in part, to this chronically heightened inflammatory state in frailty. Decrease in lipopolysaccharide (LPS)-induced proliferation of the peripheral blood mononuclear cells (PBMCs), one of the functional readouts of the innate immune system, has also been observed in frail older adults. In the adaptive immune system, significant frailty-associated alterations have been identified in the T-cell compartment including expansion of CD8+ and CCR5+ T cells and loss of CD28 expression, above and beyond age-related senescent remodeling. Moreover, frailty is associated with impaired antibody responses to pneumococcal and influenza immunization and poor clinical protection against influenza infection in community-dwelling older adults. Taken together, these findings demonstrate significant inflammatory and immune dysregulation in frail older adults and highlight the need for strategies to improve the immune function for this vulnerable elderly population.

Keywords Frailty      inflammation      IL-6      neopterin      influenza immunization     
Corresponding Authors: Sean X. Leng   
Issue Date: 01 June 2011
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Huifen Li
Bhavish Manwani
Sean X. Leng
Cite this article:   
Huifen Li,Bhavish Manwani,Sean X. Leng. Frailty, Inflammation, and Immunity[J]. Aging and Disease, 2011, 2(6): 466-473.
URL:  
http://www.aginganddisease.org/EN/     OR     http://www.aginganddisease.org/EN/Y2011/V2/I6/466
1 Fried LP, Tangen C, Walston J, Newman A, Hirsch CH, Gottdiener JS, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA(2001). Frailty in Older Adults: Evidence for a Phenotype. J Gerontol A Biol Sci Med Sci, 56A:M1-M11
2 Fried LP, Hadley EC, Walston JD, Newman A, Guralnik JM, Studenski S, Harris TB, Ershler WB, Ferrucci L(2005). From bedside to bench: research agenda for frailty. Sci Aging Knowledge Environ, 2005:e24
3 Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler WB, Harris T, Fried LP(2006). Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc, 54:991-1001
4 Lipsitz LA(2002). Dynamics of stability: the physiologic basis of functional health and frailty. J Gerontol A Biol Sci Med Sci, 57:115-25
5 Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP(2006). Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci, 61:262-6
6 Rockwood K, Andrew M, Mitnitski A(2007). A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci, 62:738-743
7 Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A, Newman AB(2005). Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc, 53:1321-1330
8 Corapi KM, McGee HM, Barker M(2006). Screening for frailty among seniors in clinical practice. Nat Clin Pract Rheumatol, 2:476-480
9 Strandberg TE, Pitkala KH(2007). Frailty in elderly people. Lancet, 369:1328-1329
10 Rockwood K, Mitnitski A(2011). Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med, 27:17-26
11 Jones DM, Song X, Rockwood K(2004). Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc, 52:1929-1933
12 Rockwood K, Mitnitski A(2007). Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci, 62:722-727
13 Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G(2004). Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci, 59:255-263
14 Fried LP, Xue QL, Cappola AR, Ferrucci L, Chaves P, Varadhan R, Guralnik JM, Leng SX, Semba RD, Walston JD, Blaum CS, Bandeen-Roche K(2009). Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci, 64:1049-1057
15 Leng SX, Tian XP, Qu T(2008). Pathophysiology of frailty: inflammatory, immune, or endocrine?. Journal of General Med (India)20:27-32
16 De MM, Franceschi C, Monti D, Ginaldi L(2006). Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol, 80:219-227
17 Roubenoff R, Parise H, Payette HA, Abad LW, D'Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB(2003). Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med, 115:429-435
18 Franceschi C, Bonafe M, Valensin S, Olivieri F, De LM, Ottaviani E, De BG(2000). Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci, 908:244-254
19 Ershler WB(1993). Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc, 41:176-81
20 Maggio M, Guralnik JM, Longo DL, Ferrucci L(2006). Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci, 61:575-584
21 Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WHJr, Heimovitz H, Cohen HJ, Wallace R(1999). Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med, 106:506-512
22 Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, Seeman TE(2002). Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc, 50:638-644
23 Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB(2002). Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci, 57:M326-M332
24 Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, Leveille SG, Fried LP, Md JM(2002). Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc, 50:1947-54
25 Leng S, Chaves P, Koenig K, Walston J(2002). Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc, 50:1268-1271
26 Leng S, Yang H, Walston J(2004). Decreased Cell Proliferation and Altered Cytokine Production in Frail Older Adults. Aging Clin Exp Res, 16:249-252
27 Leng SX, Xue QL, Tian J, Walston JD, Fried LP(2007). Inflammation and frailty in older women. J Am Geriatr Soc, 55:864-871
28 Schmaltz HN, Fried LP, Xue QL, Walston J, Leng SX, Semba RD(2005). Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc, 53:747-754
29 Walston J, Fedarko N, Yang H, Leng S, Beamer B, Espinoza S, Lipton A, Zheng H, Becker K(2008). The physical and biological characterization of a frail mouse model. J Gerontol A Biol Sci Med Sci, 63:391-398
30 Tillet W, Francis T(1930). Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. Journal of Experimental Medicine, 52:561-571
31 Hage FG, Szalai AJ(2007). C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol, 50:1115-1122
32 Walston J, McBurnie MA, Newman A, Tracy R, Kop WJ, Hirsch CH, Gottdiener JS, Fried LP(2002). Frailty and activation of the inflammation and coagulation systems with and without clinical morbidities: Results from the Cardiovascular Health Study. Arch Intern Med, 162:2333-2341
33 Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P(2005). Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol [Oxf], 63:403-411
34 Arai Y, Takayama M, Gondo Y, Inagaki H, Yamamura K, Nakazawa S, Kojima T, Ebihara Y, Shimizu K, Masui Y, Kitagawa K, Takebayashi T, Hirose N(2008). Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. J Gerontol A Biol Sci Med Sci, 63:1209-1218
35 Bruunsgaard H, ndersen-Ranberg K, Hjelmborg JB, Pedersen BK, Jeune B(2003). Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med, 115:278-283
36 Leng SX, Xue QL, Huang Y, Ferrucci L, Fried LP, Walston JD(2005). Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women. Exp Gerontol, 40:982-987
37 Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RHJr, Howard BV, Assaf AR, Prentice R(2005). Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med, 165:500-508
38 Ruggiero C, Metter EJ, Cherubini A, Maggio M, Sen R, Najjar SS, Windham GB, Ble A, Senin U, Ferrucci L(2007). White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol, 49:1841-1850
39 Leng S, Xue Q, Tian J(2009). Association of neutrophil and monocyte counts with fraily in community-dwelling older women. Experimental Gerontology, 44:511-516
40 Leng S, Xue QL, Huang Y, Semba R, Chaves P, Bandeen-Roche K, Fried L, Walston J(2005). Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med Sci, 60:195-199
41 Qu T, Yang H, Walston JD, Fedarko NS, Leng SX(2009). Upregulated monocytic expression of CXC chemokine ligand 10 [CXCL-10] and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine, 46:319-324
42 Qu T, Walston JD, Yang H, Fedarko NS, Xue QL, Beamer BA, Ferrucci L, Rose NR, Leng SX(2009). Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14[+] monocytes in frail older adults. Mech Ageing Dev, 130:161-166
43 Li DP, Periyasamy S, Jones TJ, Sanchez ER(2000). Heat and chemical shock potentiation of glucocorticoid receptor transactivation requires heat shock factor [HSF] activity. Modulation of HSF by vanadate and wortmannin. J Biol Chem, 275:26058-26065
44 Sasaki T, Wada T, Kishimoto H, Irie-Sasaki J, Matsumoto G, Goto T, Yao Z, Wakeham A, Mak TW, Suzuki A, Cho SK, Zuniga-Pflucker JC, Oliveira-dos-Santos AJ, Katada T, Nishina H, Penninger JM(2001). The stress kinase mitogen-activated protein kinase kinase [MKK]7 is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells. J Exp Med, 194:757-768
45 Barcellos-Hoff MH(2005). How tissues respond to damage at the cellular level: orchestration by transforming growth factor-{beta} [TGF-{beta}]. BJR Suppl, 27:123-127
46 Jia Y, Ransom RF, Shibanuma M, Liu C, Welsh MJ, Smoyer WE(2001). Identification and characterization of hic-5/ARA55 as an hsp27 binding protein. J Biol Chem, 276:39911-39918
47 Viswanathan K, Dhabhar FS(2005). Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc Natl Acad Sci U S A, 102:5808-5813
48 Murr C, Widner B, Wirleitner B, Fuchs D(2002). Neopterin as a marker for immune system activation. Curr Drug Metab, 3:175-187
49 Fuchs D(2008). Immune activatoin marker neopterinURL:http://www.scitopics.com/Immune_activation_marker_neopterin.html
50 Spencer ME, Jain A, Matteini A, Beamer B, Wang NY, Leng S, Punjabi NM, Walston J, Fedarko N(2010). Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI and percentage body fat. J Gerontol A Biol Sci Med, 65:858-865
51 Fahey JL, Schnelle JF, Boscardin J, Thomas JK, Gorre ME, Aziz N, Sadeghi H, Nishanian P(2000). Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev, 115:1-20
52 Solichova D, Melichar B, Blaha V, Klejna M, Vavrova J, Palicka V, Zadak Z(2001). Biochemical profile and survival in nonagenarians. Clin Biochem, 34:563-569
53 Nubling CM, Chudy M, Volkers P, Lower J(2006). Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection. Transfusion, 46:1886-1891
54 Nasonov EL, Samsonov MI, Tilz G, Fuchs D(2000). Neopterin: new immunological marker of autoimmune rheumatic disease. Klin Med [Mosk], 78:43-46
55 Leng SX, Tian X, Matteini A, Li H, Hughes J, Jain A, Walston JD, Fedarko NS(2011). IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageingin press
56 Leng SX, Cappola AR, Andersen RE, Blackman MR, Koenig K, Blair M, Walston JD(2004). Serum levels of insulin-like growth factor-I [IGF-I] and dehydroepiandrosterone sulfate [DHEA-S], and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res, 16:153-157
57 Leng SX, Hung W, Cappola AR, Yu Q, Xue QL, Fried LP(2009). White blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older women. J Gerontol A Biol Sci Med Sci, 64:499-502
58 Semba RD, Bartali B, Zhou J, Blaum C, Ko CW, Fried LP(2006). Low serum micronutrient concentrations predict frailty among older women living in the community. J Gerontol A Biol Sci Med Sci, 61:594-599
59 Michelon E, Blaum C, Semba RD, Xue QL, Ricks MO, Fried LP(2006). Vitamin and carotenoid status in older women: associations with the frailty syndrome. J Gerontol A Biol Sci Med Sci, 61:600-607
60 Vasto S, Mocchegiani E, Malavolta M, Cuppari I, Listi F, Nuzzo D, Ditta V, Candore G, Caruso C(2007). Zinc and inflammatory/immune response in aging. Ann N Y Acad Sci, 1100:111-122
61 LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Newman AB, Kooperberg CL, Black H, Curb JD, Greenland P, Woods NF(2008). Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci, 63:369-375
62 Semba RD, Margolick JB, Leng S, Walston J, Ricks MO, Fried LP(2005). T cell subsets and mortality in older community-dwelling women. Exp Gerontol, 40:81-87
63 Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, Margolick JB(2007). HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci, 62:1279-1286
64 Desquilbet L, Margolick JB, Fried LP, Phair JP, Jamieson BD, Holloway M, Jacobson LP(2009). Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr, 50:299-306
65 De FU, Wang GC, Fedarko NS, Walston JD, Casolaro V, Leng SX(2008). T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults. J Am Geriatr Soc, 56:904-908
66 Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM(1998). CCR5 is characteristic of Th1 lymphocytes. Nature, 391:344-5
67 Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR(1998). The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest, 101:746-754
68 Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR(1996). Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86:367-377
69 Fatkenheuer G, Pozniak AL, Johnson MA, Plettenberg A, Staszewski S, Hoepelman AI, Saag MS, Goebel FD, Rockstroh JK, Dezube BJ, Jenkins TM, Medhurst C, Sullivan JF, Ridgway C, Abel S, James IT, Youle M, van der Ryst E(2005). Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med, 11:1170-2
70 Gibson KL, Wu YC, Barnett Y, Duggan O, Vaughan R, Kondeatis E, Nilsson BO, Wikby A, Kipling D, Dunn-Walters DK(2009). B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell, 8:18-25
71 Ridda I, MacIntyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, McIntyre PB(2009). Immunological responses to pneumococcal vaccine in frail older people. Vaccine, 27:1628-1636
72 Yao X, Hamilton RG, Weng NP, Xue QL, Bream JH, Li H, Tian J, Yeh SH, Resnick B, Xu X, Walston J, Fried LP, Leng SX(2011). Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccinein press
[1] Christina Brandenberger,Katharina Maria Kling,Marius Vital,Mühlfeld Christian. The Role of Pulmonary and Systemic Immunosenescence in Acute Lung Injury[J]. A&D, 2018, 9(4): 553-565.
[2] Jiao Lu,Xuefeng Duan,Wenming Zhao,Jing Wang,Haoyu Wang,Kai Zhou,Min Fang. Aged Mice are More Resistant to Influenza Virus Infection due to Reduced Inflammation and Lung Pathology[J]. A&D, 2018, 9(3): 358-373.
[3] Yali Chen,Mengmei Yin,Xuejin Cao,Gang Hu,Ming Xiao. Pro- and Anti-inflammatory Effects of High Cholesterol Diet on Aged Brain[J]. A&D, 2018, 9(3): 374-390.
[4] Can Zhang,Nicole R. Brandon,Kerryann Koper,Pei Tang,Yan Xu,Huanyu Dou. Invasion of Peripheral Immune Cells into Brain Parenchyma after Cardiac Arrest and Resuscitation[J]. A&D, 2018, 9(3): 412-425.
[5] Emma EF. Kleipool,Emiel O. Hoogendijk,Marijke C. Trappenburg,M. Louis Handoko,Martijn Huisman,Mike JL. Peters,Majon Muller. Frailty in Older Adults with Cardiovascular Disease: Cause, Effect or Both?[J]. A&D, 2018, 9(3): 489-497.
[6] Chengjie Zhang,Yanbing Zhu,Song Wang,Zheng Zachory Wei,Michael Qize Jiang,Yongbo Zhang,Yuhualei Pan,Shaoxin Tao,Jimei Li,Ling Wei. Temporal Gene Expression Profiles after Focal Cerebral Ischemia in Mice[J]. A&D, 2018, 9(2): 249-261.
[7] Hidemi Takeuchi,Haruhito A. Uchida,Yuki Kakio,Yuka Okuyama,Michihiro Okuyama,Ryoko Umebayashi,Kentaro Wada,Hitoshi Sugiyama,Ken Sugimoto,Hiromi Rakugi,Jun Wada. The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients[J]. A&D, 2018, 9(2): 192-207.
[8] Pedro Carrera-Bastos,Óscar Picazo,Maelán Fontes-Villalba,Helios Pareja-Galeano,Staffan Lindeberg,Manuel Martínez-Selles,Alejandro Lucia,Enzo Emanuele. Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction[J]. A&D, 2018, 9(2): 317-321.
[9] Mari L. Sbardelotto,Giulia S. Pedroso,Fernanda T. Pereira,Helen R. Soratto,Stella MS. Brescianini,Pauline S. Effting,Anand Thirupathi,Renata T. Nesi,Paulo CL. Silveira,Ricardo A. Pinho. The Effects of Physical Training are Varied and Occur in an Exercise Type-Dependent Manner in Elderly Men[J]. A&D, 2017, 8(6): 887-898.
[10] Adar Zinger,William C Cho,Arie Ben-Yehuda. Cancer and Aging - the Inflammatory Connection[J]. A&D, 2017, 8(5): 611-627.
[11] Ulises Urzua,Carlos Chacon,Luis Lizama,Sebastián Sarmiento,Pía Villalobos,Belén Kroxato,Katherine Marcelain,María-Julieta Gonzalez. Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice[J]. A&D, 2017, 8(5): 546-557.
[12] Ilia Stambler. Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy[J]. A&D, 2017, 8(5): 583-589.
[13] Lucia Tortorella,Giuseppe Vizzielli,Domenico Fusco,William C. Cho,Roberto Bernabei,Giovanni Scambia,Giuseppe Colloca. Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments[J]. A&D, 2017, 8(5): 677-684.
[14] Zohara Sternberg,Zihua Hu,Daniel Sternberg,Shayan Waseh,Joseph F. Quinn,Katharine Wild,Kaye Jeffrey,Lin Zhao,Michael Garrick. Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease[J]. A&D, 2017, 8(2): 215-227.
[15] Iranzu Mugueta-Aguinaga, Begonya Garcia-Zapirain. Is Technology Present in Frailty? Technology a Back-up Tool for Dealing with Frailty in the Elderly: A Systematic Review[J]. A&D, 2017, 8(2): 176-195.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd